IGF-1 LR3

Overview

IGF-1 LR3 is a modified version of insulin-like growth factor-1 (IGF-1), engineered to have a significantly longer half-life and increased biological activity compared to natural IGF-1.

It is widely studied in research settings for its role in muscle growth signaling, cellular regeneration, metabolism, and tissue repair.

Mechanism of Action

IGF-1 LR3 binds to IGF-1 receptors throughout the body and activates intracellular signaling pathways involved in growth and repair. It may:

• Promote protein synthesis in muscle tissue.
• Stimulate cellular growth and proliferation.
• Enhance nutrient uptake into muscle cells.
• Support tissue regeneration and repair.
• Increase satellite cell activation (muscle repair cells).
• Influence glucose and energy metabolism.

The “LR3” modification reduces binding to IGF-binding proteins, increasing its availability and duration of action.

Research Applications

IGF-1 LR3 has been investigated in:

• Muscle hypertrophy and performance research.
• Tissue repair and regeneration studies.
• Metabolic function research.
• Nerve and cellular growth studies.
• Aging and recovery research.
• Insulin and glucose metabolism studies.

Potential Effects Observed in Studies

Research suggests IGF-1 LR3 may:

• Increase lean muscle mass.
• Enhance muscle recovery and repair.
• Improve nutrient partitioning into muscle tissue.
• Promote cellular regeneration.
• Support fat metabolism indirectly.
• Improve recovery from injury or intense training.

Possible Side Effects

Reported or potential side effects may include:

• Hypoglycemia (low blood sugar).
• Joint or muscle discomfort.
• Water retention.
• Headache.
• Tingling sensations.
• Fatigue or lethargy.
• Potential insulin sensitivity changes.

Because it affects growth signaling pathways, effects can be systemic.

Precautions

• Long-term safety in humans is not fully established.
• Blood glucose monitoring may be important in research settings.
• Caution in individuals with cancer risk due to growth signaling pathways.
• Product quality and dosing accuracy are critical in research use.

Storage

• Typically supplied as a lyophilized (freeze-dried) peptide.
• Store refrigerated (2–8°C).
• Protect from heat, light, and moisture.
• Refrigerate after reconstitution.
• Avoid repeated freeze–thaw cycles.

Packaging

Common Product Formats:

• 0.1 mg, 1 mg, or 5 mg vials.
• Research-grade peptide formulations.
• Injectable laboratory preparations.

Summary

IGF-1 LR3 is a long-acting modified form of insulin-like growth factor-1 that enhances anabolic signaling, muscle growth, and cellular repair. Due to its increased potency and extended half-life, it is widely studied in research related to muscle hypertrophy, recovery, metabolic regulation, and tissue regeneration.